Shay Capital LLC Bicycle Therapeutics PLC Transaction History
Shay Capital LLC
- $606 Million
- Q1 2025
A detailed history of Shay Capital LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Shay Capital LLC holds 60,000 shares of BCYC stock, worth $517,800. This represents 0.08% of its overall portfolio holdings.
Number of Shares
60,000Holding current value
$517,800% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding BCYC
# of Institutions
100Shares Held
42.7MCall Options Held
15.6KPut Options Held
27.7K-
Baker Bros. Advisors LP New York, NY10.9MShares$93.9 Million1.1% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.69MShares$31.9 Million0.08% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$29.8 Million7.08% of portfolio
-
Armistice Capital, LLC New York, NY2.67MShares$23.1 Million0.35% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.66MShares$22.9 Million0.12% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $256M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...